Literature DB >> 9834056

Identification of the 2B4 molecule as a counter-receptor for CD48.

Y Latchman1, P F McKay, H Reiser.   

Abstract

The CD48 molecule belongs to a subfamily of the Ig superfamily that also includes the CD2, CD58, 2B4, Signaling lymphocyte activation molecule (SLAM), and Ly-9 molecules. Receptor-ligand interactions are known to occur between several members of this family, and these interactions can strengthen cell to cell adhesion. In mice, the CD48 molecule can bind to CD2. To search for additional ligands of murine CD48, we have generated a chimeric fusion protein consisting of the extracellular domain of murine CD48 and the C region of human IgG1. The results of immunofluorescence and immunoprecipitation experiments in which this reagent was used identify the 2B4 molecule as a novel counter-receptor of CD48.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834056

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  A novel immunoglobulin superfamily receptor (19A) related to CD2 is expressed on activated lymphocytes and promotes homotypic B-cell adhesion.

Authors:  John J Murphy; Paul Hobby; Juan Vilarino-Varela; Benjamin Bishop; Panagiota Iordanidou; Brian J Sutton; John D Norton
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

Review 2.  Novel anti-myeloma immunotherapies targeting the SLAM family of receptors.

Authors:  Sabarinath Venniyil Radhakrishnan; Neelam Bhardwaj; Tim Luetkens; Djordje Atanackovic
Journal:  Oncoimmunology       Date:  2017-03-28       Impact factor: 8.110

3.  Altered expression of signalling lymphocyte activation molecule (SLAM) family receptors CS1 (CD319) and 2B4 (CD244) in patients with systemic lupus erythematosus.

Authors:  J R Kim; S O Mathew; R K Patel; R M Pertusi; P A Mathew
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

4.  Expansion and diversification of the signaling capabilities of the CD2/SLAM family in Xenopodinae amphibians.

Authors:  Sergey V Guselnikov; Petr P Laktionov; Alexander M Najakshin; Konstantin O Baranov; Alexander V Taranin
Journal:  Immunogenetics       Date:  2011-06-11       Impact factor: 2.846

5.  Glycosylation affects ligand binding and function of the activating natural killer cell receptor 2B4 (CD244) protein.

Authors:  Stefanie Margraf-Schönfeld; Carolin Böhm; Carsten Watzl
Journal:  J Biol Chem       Date:  2011-05-23       Impact factor: 5.157

6.  Human Herpesvirus 6B Downregulates Expression of Activating Ligands during Lytic Infection To Escape Elimination by Natural Killer Cells.

Authors:  Dominik Schmiedel; Julie Tai; Francesca Levi-Schaffer; Sarah Dovrat; Ofer Mandelboim
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

7.  2B4+ CD8+ T cells play an inhibitory role against constrained HIV epitopes.

Authors:  Kim N Aldy; Nathan C Horton; Porunelloor A Mathew; Stephen O Mathew
Journal:  Biochem Biophys Res Commun       Date:  2011-01-21       Impact factor: 3.575

8.  Properties of human blood monocytes. II. Monocytes from healthy adults are highly heterogeneous within and among individuals.

Authors:  Dorothy Hudig; Kenneth W Hunter; W John Diamond; Doug Redelman
Journal:  Cytometry B Clin Cytom       Date:  2013-12-10       Impact factor: 3.058

9.  Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family.

Authors:  C Alejandro Velikovsky; Lu Deng; Lukasz K Chlewicki; Marisa M Fernández; Vinay Kumar; Roy A Mariuzza
Journal:  Immunity       Date:  2007-10-18       Impact factor: 31.745

Review 10.  Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.

Authors:  Elia Moreno-Cubero; Juan-Ramón Larrubia
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.